PROAXIS THERAPY, LLC – Trademark Portfolio

Entity Type: 16

PROAXIS THERAPY, LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include P PROAXIS THERAPY. The owner is based in GREENVILLE, SC.

103 N. MAIN STREET

GREENVILLE, SC 29601

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

PROAXIS THERAPY, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does PROAXIS THERAPY, LLC have?

PROAXIS THERAPY, LLC has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does PROAXIS THERAPY, LLC file in?

PROAXIS THERAPY, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are PROAXIS THERAPY, LLC's most well-known trademarks?

PROAXIS THERAPY, LLC's registered trademark portfolio includes well-known marks such as P PROAXIS THERAPY. These are among 2 currently registered trademarks in the portfolio.

What is PROAXIS THERAPY, LLC's trademark registration success rate?

PROAXIS THERAPY, LLC has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.